Issue 5/2013

Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter (469 — 479)

Z. WANG, X. ZHOU, J. LI, X. LIU, Z. CHEN, G. SHEN, T. GUAN, N. YE, X. WEI, N. HUANG, L. YANG, Y. WEI, J. LI

DOI: 10.4149/neo_2013_061

Expression of ki-67 and p53 in meningiomas (480 — 485)

S. PAVELIN, K. BECIC, G. FOREMPOHER, I. MRKLIC, Z. POGORELIC, M. TITLIC, S. ANDELINOVIC

DOI: 10.4149/neo_2013_062

Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis (486 — 492)

R. QIN, Z. CHEN, Y. DING, J. HAO, J. HU, F. GUO

DOI: 10.4149/neo_2013_063

p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion (493 — 503)

W. LU, Y. H. XIA, J. J. QU, Y. Y. HE, B. L. LI, C. LU, X. LUO, X. P. WAN

DOI: 10.4149/neo_2013_064

Establishment of an animal model of spontaneous cervical lymph node metastasis of laryngeal squamous cell carcinoma and obtaining laryngocarcinoma cells with high metastatic potential (504 — 510)

L. W. CHEN, J. L. WANG, L. Y. ZHANG, S. M. YANG, C. S. LI, N. YU, J. D. ZHAO,W. W. GUO, L. D. ZHAO, K. LI, M. B. LIU, S. Q. ZHAI

DOI: 10.4149/neo_2013_065

MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration (511 — 515)

H. LI, J. ZHAO, J. W. ZHANG, Q. Y. HUANG, J. Z. HUANG, L. S. CHI, H. J. TANG, G. Q. LIU, D. J. ZHU, W. M. MA

DOI: 10.4149/neo_2013_066

Podoplanin expression in cancer-associated fibroblasts correlates with VEGF-C expression in cancer cells of invasive ductal breast carcinoma (516 — 524)

B. PULA, A. WOJNAR, W. WITKIEWICZ, P. DZIEGIEL, M. PODHORSKA-OKOLOW

DOI: 10.4149/neo_2013_067

Immunotherapy with tumor cell lysate-pulsed CD8α+ dendritic cells modulates intra-tumor and spleen lymphocyte subpopulations (525 — 533)

A. AZADMEHR, A. A. POURFATHOLLAH, Z. AMIRGHOFRAN, Z. M. HASSAN, S. M. MOAZZENI

DOI: 10.4149/neo_2013_068

Fluorescence characteristics of human urine from normal individuals and ovarian cancer patients (533 — 537)

M. ZVARIK, D. MARTINICKY, L. HUNAKOVA, I. LAJDOVA, L. SIKUROVA

DOI: 10.4149/neo_2013_069

Individualized treatment of NSCLC: From research to clinical practice (538 — 545)

Y. WANG, Z. D. LIU, L. M. ZHAO, C. X. DU, X. M. XI, Y. L. MI, Y. PENG, W. G. LI, F. CHENG, X. R. ZHANG, Y. Q. ZHENG, K. K. TANG, H. Y. YANG, D. T. CHU

DOI: 10.4149/neo_2013_070

Clinical significance of ascites in epithelial ovarian cancer (546 — 552)

H. HUANG, Y. J. LI, C. Y. LAN, Q. D. HUANG, Y. L. FENG, Y. W. HUANG, J. H. LIU

DOI: 10.4149/neo_2013_071

Clinical importance of myeloid antigen expression in Moroccan patients with adult B-lineage acute lymphoblastic leukemia. (553 — 560)

A. LAHJOUJI, F. BACHIR, S. BENNANI, S. BENCHEKROUN, S. AMZAZI,R. E. AOUAD

DOI: 10.4149/neo_2013_072

Cetuximab plus chemotherapy as first-line treatment for metastatic colorectal cancer: Effect of KRAS mutation on treatment efficacy in Taiwanese patients (561 — 567)

M. C. CHEN, F. F. CHIANG, H. M. WANG

DOI: 10.4149/neo_2013_073

Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer (568 — 575)

O. VRNDIC, O. MILOSEVIC-DJORDJEVIC, P. DJURDJEVIC, D. JOVANOVIC, L. MIJATOVIC, I. JEFTIC, S. ZIVANCEVIC SIMONOVIC

DOI: 10.4149/neo_2013_074

The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: An analysis of 96 allografted AML patients ≥50 years from the Czech acute leukaemia clinical register (alert) (576 — 583)

P. JINDRA, J. MUZIK, K. INDRAK, P. ZAK, F. A. SABTY, T. KOZAK, P. CETKOVSKY, V. KOZA,M. KARAS, L. RAIDA, T. SZOTKOWSKI

DOI: 10.4149/neo_2013_075